Directorate General of Pharmaceutical Affairs, Ministry of Health, Sultanate of Oman
12.2013 - Current
Associate Professor
Muscat, Sultanate of Oman, Industrial Pharmacy at the College of Pharmacy & Nursing, University of Nizwa
01.2011 - 12.2013
Sultanate of Oman
01.2010 - 11.2013
Training Consultant
Muscat, Sultanate of Oman, CGMP, Ministry of Health
03.2012 - 12.2012
Directorate General of Pharmaceutical Affairs and Drug control
Bioequivalence studies assessment Consultant
Ministry of Health
01.2010 - 01.2010
Directorate General of Pharmaceutical Affairs and Drug control
Technical Training Center Manager
Gulf Pharmaceutical Industries, Al Khaimah, Arab Emirates
11.2006 - 11.2009
Visiting lecturer
Dubai Pharmacy College, DPC, Pharmacy College, Ras Al Khaimah University, Ras, Arab Emirates, Martin Luther University
11.2006 - 11.2009
Post Doctorate at the Institute of Pharmacology and Toxicology, Section of Pharmacokinetics, Faculty of Medicine
Certified Researcher
Halle, Animals, Sachsen-Anhalt, Ministry of Health
Wittenberg
03.2004 - 10.2006
Halle
Wittenberg
03.2004 - 10.2004
Evaluation of all vaccines (8 vaccines) against the Coronavirus that are emergency used authorized in Oman, as well as antiviral (3) and Monoclonal Antibodies (3) drugs
Evaluation of more than 1100 GCC & Local clinical, Bioequivalence & Biowaiver (M5) studies for NDA & ANDA drug products
Evaluation of biotechnology & biosimilar products, including Covid-19 Vaccines, Monoclonal AB & Antiviral drugs
Evaluation of all SUPAC Variation types
Updating Local & GCC Guidelines as a member of the cGMP & Bioequivalence committees
Staff Training in the field of cGMP, GLP, Bioanalytical & clinical, and Bioequivalence studies
Updating presentations regarding the international pharma Industry Guidelines
Updating presentations regarding Covid-19 vaccines & treatment possibilities during the Covid-19 Pandemic time
Editorial Board member of the PHARMACEUTICAL NEWSLETTER of the Directorate General of Pharmaceutical Affairs and Drug control, Ministry of Health, Muscat, Sultanate of Oman., Clinical Pharmacokinetic for human and dental medicine students at
Clinical Pharmacokinetic
College of Pharmacy & Nursing, Nizwa University
01.2000 - 01.2003
Of Oman
Pharmaceutical and Medicinal Chemistry, College of Pharmacy& Nursing
Nizwa University
Sultanate of Oman
Drug Discovery for the final year students
Dubai Pharmacy College
Dubai
Clinical Pharmacology for both undergraduate and graduate levels
Martin Luther University
Halle, Wittenberg
Physical Chemistry for biology, chemistry & pharmacy students
Christian Albrecht University Kiel
05.2022 - 1 1
Clinical Studies:
PK/PD Model: Langendorff-perfused rat heart
Cardiac uptake and negative inotropic response of verapamil in rat heart: Effect of amiodaron
(Pharmaceutical Research, Volume 24, Number 1, January 2007, pp
48-57(10)
Cardiac pharmacokinetics and inotropic response of verapamil in rats with endotoxemia, Pakawadee Sermsappasuk, Osama Abdelrahman, Michael Weiss, Journal of Pharmaceutical Sciences,2007, Volume 97 Issue 7, Pages 2798 – 2804
Cardiac pharmacokinetics and inotropic response of verapamil in rats with endotoxemia, Journal of Pharmaceutical Sciences, Published online in Wiley InterScience (www.interscience.wiley.com)
DOI 10.1002/jps.21021
Digoxin uptake, receptor heterogeneity, and inotropic response in the presence of staurosporine
Drug interaction between verapamil and p-glycoprotein inhibitor (amiodarone)
Pharmacokinetics and pharmacodynamics of idarubicin liposomes in perfused Langendorff rat hearts
Mass Spectrometry:
Nano- and Femtosecond Laser Mass Spectrometry of Organic Molecules and Cluster, Osama Abdel Rahman and Jürgen Grotemeyer, ads, NASA (The Smithsonian/NASA Astrophysics data System) AIP Conf
Proc
March 17, 2009, Volume 1104, pp
62-72
Nano- and Femtosecond Laser Mass Spectrometry of Organic Molecules and Cluster, Rahman, Osama Abdel; Grotemeyer, Juergen, Journal Name: AIP Conference Proceedings; Journal Volume: 1104; Journal Issue: 1; Conference: LAP 2008: 4
International conference on laser probing, Nagoya (Japan), 6-10 Oct 2008; Other Information: DOI: 10.1063/1.3115611; (c) 2009 American Institute of Physics; Country of input: International Atomic Energy Agency (IAEA)
O.A
Rahman and J
Grotemeyer Formation and reactions of clusters in the gas phase: small peptides and carboxylic acids
The mobile proton in biomolecular clusters: Tripeptides and vanillic acid Osama Abdelrahman, Barbara Grotemeyer, Jürgen Grotemeyer, International Journal of Mass Spectrometry, Volumes 354–355, 15 November 2013, Pages 3
Cluster Formation and Fragmentation of Amino Acids and small peptides observed by Multiphoton Ionization
49th ASMS Conference on Mass Spectrometry and Allied Topics, Chicago, Illinois, 2001, Web Publication
Proton Transfer Reactions in Peptide Clusters (52nd ASMS Conference on Mass Spectrometry, Nashville, Tennessee, USA, Web Publication
Untersuchung der Bildung biologischer Cluster und Peptidbildung in der Gasphase
DGMS 2001, Technische Universität München
Peptide Clusters in the gas phase, DGMS-2002, Deutsches Krebsforschungszentrum Heidelberg http://www.dkfz-heidelberg.de/spec2/dgms2002/teilnehmer.htm
The Formation of Peptide Bonding in Small Peptide Clusters in the Gas Phase, DGMS-2003 Universität Münster
Peptide Clusters in the Gaseous Phase, Dissertationsabstract, Universität Kiel, Dez
2003 Web Publication http://e-diss.uni-kiel.de/diss_962/
Cluster Formation and Fragmentation of Medium-sized Peptides Observed by Multi- Photon Ionization “http://www.iibb.csic.es/seem/web/esp/noticias/pasadas/16thimsc/16thimsc_posters2.html"
CONFERENCES & SYMPOSIUMS
Speaker in a diverse of International scientific conferences (listed only some of them):
Speaker in the 4th MENA Regulatory Conference on Bioequivalence, Biowaivers, Bioanalysis and Dissolution in Amman, Jordan, September 19th and 20th 2022.
Education
Ph.D - Pharmacy
Christian Albrecht University Kiel
Ph.D - undefined
Christian Albrecht University, Bayer
undefined
Christian Albrecht University
05.2000 - 10.2000
undefined
04.1994 - 01.2000
German language courses - undefined
Christian Albrecht University
10.1992 - 04.1994
Bachelor of Science - Chemistry department
Christian Albrecht University
04.1991 - 10.1992
undefined
Suez Canal university
01.1984 - 01.1989
Skills
COMPUTER SKILLSundefined
Accomplishments
PHARMACIST / CHEMIST
Drug affairs Consultant at the Directorate General of Pharmaceutical Affairs and Drug control, Ministry of Health
Muscat, Sultanate of Oman
“Evaluator of all vaccines (8 vaccines) against the Coronavirus (Covid-19) that are emergency used authorized in Oman, as well as antiviral (3 drugs) and Monoclonal Antibodies (3 drugs)”
PERSONAL INFORMATION & CONTACT
Phone:, Biosimilars & Bioequivalence studies regulations: “Similarities and Differences Among EMA, FDA, WHO & GCC Requirements”
Speaker in the 5th Symposium on “Harmonization of Bioequivalence Requirements” HBR5 in Dead Sea – Jordan, 25 & 26 February 2020
Speaker in the 4th Symposium on Harmonization of Bioequivalence Requirements organized by ACDIMA in Dead Sea – Jordan, 10-11 of April 2019
Speaker in the 2rd Symposium On Harmonization Of Bioequivalence Requirements organized by ACDIMA in Amman, 30-31 of Oct.2017
Virtual Speaker in the International Conference of Pharmacy and Medicine on 18th to 20th of January 2021
Topic: Antiviral drugs against Covid-19
Speaker in the 3rd International Conference of Pharmacy and Medicine (ICPM) at Ajman University, UAE in 19-21 November 2019
Speaker in the 2nd International Conference of Pharmacy and Medicine (ICPM) at Sharjah University, UAE in 18-21 November 2018
Speaker in the 1st International Conference of Pharmacy and Medicine (ICPM) at Ajman University, UAE in 9-11 November 2017
Holding seminar with the title “Generikum, Cases for good substitution practice, (Aut - Idem Substitution) “in the American University of Sharjah, Dubai Pharmacy college, Nizwa Pharmacy College- Sultanate Oman (Seminars for 3 days) & in the Pharmacist Day (RAK)
Holding Seminar with the title (Population Pharmacokinetics) at Hoffmann-La Roche, Basel Switzerland, On March 2006.
Timeline
Christian Albrecht University Kiel
05.2022 - 1 1
Drug affairs Consultant
Directorate General of Pharmaceutical Affairs, Ministry of Health, Sultanate of Oman
12.2013 - Current
Training Consultant
Muscat, Sultanate of Oman, CGMP, Ministry of Health
03.2012 - 12.2012
Associate Professor
Muscat, Sultanate of Oman, Industrial Pharmacy at the College of Pharmacy & Nursing, University of Nizwa
01.2011 - 12.2013
Sultanate of Oman
01.2010 - 11.2013
Bioequivalence studies assessment Consultant
Ministry of Health
01.2010 - 01.2010
Technical Training Center Manager
Gulf Pharmaceutical Industries, Al Khaimah, Arab Emirates
11.2006 - 11.2009
Visiting lecturer
Dubai Pharmacy College, DPC, Pharmacy College, Ras Al Khaimah University, Ras, Arab Emirates, Martin Luther University
11.2006 - 11.2009
Certified Researcher
Halle, Animals, Sachsen-Anhalt, Ministry of Health
General Practitioner Resident at Ministry Of Health - General Directorate of Health Affairs In HailGeneral Practitioner Resident at Ministry Of Health - General Directorate of Health Affairs In Hail
Head of Pharmaceutical Care, Operations at Ministry of Health, The Sultanate of OmanHead of Pharmaceutical Care, Operations at Ministry of Health, The Sultanate of Oman
Assistant Manager – Drug Regulatory Affairs at Intas Pharmaceuticals LimitedAssistant Manager – Drug Regulatory Affairs at Intas Pharmaceuticals Limited